Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Physiomics Share Price
  4. Physiomics Share Regulatory News
  5. Board Changes

Pin to quick picksPhysiomics Regulatory News (PYC)

Physiomics Information

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes
Get Live Data
0.625    -0.025 (-3.85%)
Bid:
0.60
Ask:
0.65
Spread: 0.05 (8.333%)
Market Cap: £2.83m
PYC Live PriceLast checked at - London Stock Exchange

Intraday Physiomics Share Chart

Board Changes

20 Dec 2007 11:15

Physiomics PLC20 December 2007 20 December 2007 Physiomics plc ("Physiomics" or "the Company") Board changes The Company announces the resignation as directors of John Pool, DuncanLipscombe and Edward Oliver with immediate effect. The board of directors ofPhysiomics would like to express its gratitude to them for all their efforts onbehalf of the Company. Resolutions proposing the re-election as directors of John Pool and DuncanLipscombe at the annual general meeting to be held on 21 December 2007 will nowbe withdrawn. Paul Harper has agreed to act as chairman and further appointmentsare expected to be announced in due course. For further information: Physiomics plc 07747 842446Dr Paul Harper, Chairman Grant Thornton Corporate Finance 020 7383 5100Philip Secrett, Colin Aaronson" This information is provided by RNS The company news service from the London Stock Exchange
12345678910
Date   Source Headline
29th Apr 20154:27 pmRNSHolding(s) in Company
22nd Apr 20157:00 amRNSVirtual Tumour platform - AACR Annual Meeting 2015
26th Mar 20157:00 amRNSIssue of Options
17th Mar 20157:00 amRNSHalf Yearly Report
12th Mar 20157:00 amRNSIssue of Equity
6th Mar 20151:40 pmRNSHolding(s) in Company
4th Mar 201511:56 amRNSHolding(s) in Company
3rd Mar 201512:57 pmRNSFirst contract for clinical version of Virtu
20th Feb 201512:34 pmRNSHolding(s) in Company
2nd Feb 20157:00 amRNSTermination of Equity Swap Agreement
15th Dec 20141:08 pmRNSResult of AGM
12th Nov 201410:24 amRNSFinal Results
4th Nov 20147:00 amRNSDisclosure of Large Pharma partner Merck & Co
27th Oct 201410:07 amRNSProject extension with global pharma company
13th Oct 20144:43 pmRNSHolding(s) in Company
7th Oct 20149:35 amRNSCardiotox Platform Launch
29th Aug 20142:47 pmRNSHolding(s) in Company
14th Aug 20141:10 pmRNSNew deal with global pharma
24th Jul 201412:59 pmRNSIssue of Equity
26th Jun 20147:57 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSAnticipated new collaboration with Diatech
20th May 20149:47 amRNSHolding(s) in Company
10th Apr 20147:00 amRNSSecond validation of Virtual Tumour Clinical
14th Feb 20147:00 amRNSHalf Yearly Report
30th Jan 20144:41 pmRNSIssue of Equity - Replacement
30th Jan 20143:02 pmRNSIssue of Equity
16th Jan 20147:20 amRNSDundee University Collaboration
17th Dec 20132:07 pmRNSResult of AGM
4th Dec 201310:47 amRNSVirtual Tumour Proposal
28th Nov 20131:24 pmRNSDrugCARD launch
15th Nov 20137:00 amRNSFinal Results
11th Nov 20137:00 amRNSUniversity of Oxford Collaboration
4th Nov 20137:00 amRNSUpdate on the Virtual Tumour Clinical platform
10th Oct 201310:30 amRNSDrawdown pursuant to SEDA Arrngmnt/Issue of Equity
7th Oct 20138:32 amRNSPhysiomics gains new speciality pharma customer
1st Oct 201311:49 amRNSPhysiomics gains first large pharma customer
16th Sep 20137:00 amRNSPhysiomics to present cardiac toxicity platform
26th Jul 20131:30 pmRNSIssue of Equity
1st Jul 20137:00 amRNSAdditional SEDA Drawdown
24th Jun 20137:00 amRNSWins Poster Award
20th Jun 20134:28 pmRNSAward of Grant
11th Jun 20137:00 amRNSPopulation Approach Group Europe
6th Jun 20137:00 amRNSVirtual Tumour Clinical Contract
8th Apr 20138:03 amRNSPhysiomics to present new developments
25th Mar 20137:00 amRNSPhysiomics to provide cardiac toxicity modelling
18th Mar 20137:00 amRNSNew clinical PK/PD modelling service
13th Feb 201311:10 amRNSIssue of Options
11th Feb 20133:23 pmRNSDirector Declaration
8th Feb 20137:00 amRNSHalf Yearly Report
22nd Jan 20137:00 amRNSSEDA Arrangement
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
CHRT
Cohort
LSE
1.59%
PCT
Polar Capital Technology Trust
LSE
-2.54%
SPAG
Ishr Agribus
LSE
-0.89%
EWG
EW Group
LSE
-1.08%
PYC
Physiomics
LSE
-3.85%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
0.00%
GEX
Georgina Energy
LSE
1.69%
PREM
Premier African Minerals
LSE
-16.00%
PANR
Pantheon Resources plc
LSE
31.07%
ALRT
Defence Holdings
LSE
0.00%